Risk factorsBy Mayo Clinic Staff
By age 2, most children will have been infected with respiratory syncytial virus. Children who attend child care centers or who have siblings who attend school are at a higher risk of exposure. Susceptibility is also greater during the peak RSV season, which typically begins in the fall and ends in the spring.
People at increased risk of severe — sometimes life-threatening — infections include:
July 09, 2014
- Infants younger than 6 months of age
- Younger children, especially under 1 year of age, who were born prematurely or who have an underlying condition, such as congenital heart or lung disease
- Children with weakened immune systems, such as those undergoing chemotherapy or transplantation
- Infants in crowded child care settings
- Older adults
- Adults with asthma, congestive heart failure or chronic obstructive pulmonary disease
- People with immunodeficiency, including those with certain transplanted organs, leukemia or HIV/AIDS
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed May 14, 2014.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed May 14, 2014.
- Respiratory syncytial virus infection (RSV). Centers for Disease Control and Prevention. http://www.cdc.gov/rsv. Accessed May 14, 2014.
- Understanding RSV. American Lung Association. http://www.lung.org/lung-disease/respiratory-syncytial-virus/understanding-rsv.html. Accessed May 14, 2014.
- Kliegman RM, et al. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, Pa.: Saunders Elsevier; 2011. http://www.clinicalkey.com. Accessed May 15, 2014.
- Respiratory syncytial virus infection (RSV) — Treatment. National Institute of Allergy and Infectious Diseases. http://www.niaid.nih.gov/topics/rsv/understanding/Pages/treatment.aspx. Accessed May 15, 2014.
- Barr FE, et al. Respiratory syncytial virus infection: Treatment. http://www.uptodate.com/home. Accessed May 15, 2014.
- Symptom relief. Centers for Disease Control and Prevention. http://www.cdc.gov/getsmart/antibiotic-use/symptom-relief.html. Accessed May 15, 2014.
- Policy statement — Modified recommendations for use of Palivizumab for prevention of respiratory syncytial virus infections. American Academy of Pediatrics Policy. http://aappolicy.aappublications.org. Accessed May 14, 2014.